Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2005
09/14/2005CN1668323A Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
09/14/2005CN1668316A Anti-spasmodic comprising xenon
09/14/2005CN1668314A Methods of treating hepatitis
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668309A Trimegestone and estrogens for treating post menopausal disorders
09/14/2005CN1668308A Oxazolidinone derivatives as antimicrobials
09/14/2005CN1668305A Microbicidal pyrimidine or triazine for preventing sexual HIV transmission
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668293A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
09/14/2005CN1666991A Processes for preparing clarithromycin polymorphs and novel polymorph IV
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666984A Process for extracting epigoitrin from isatis root and use thereof
09/14/2005CN1666768A Medicinal composition for treating epidemic infectious disease and preparation process thereof
09/14/2005CN1666765A Natural antioxidant with human immunity-enhancing and virus-preventing functions
09/14/2005CN1666762A Chinese medicine for treating AIDS
09/14/2005CN1666757A AIDS-rehabilitating capsule
09/14/2005CN1666746A Laevulose injection of antiviral drug
09/14/2005CN1666744A Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof
09/14/2005CN1666743A 复方头孢克洛分散片 Compound Cefaclor tablet
09/14/2005CN1666742A Combination therapy to treat hepatitis b virus
09/14/2005CN1218958C Novel cyclosporin with improved activity profile
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218933C Acylhydrazone compound, preparing method and use thereof
09/14/2005CN1218751C Two-element active antibody preparation and its preparing process
09/14/2005CN1218750C Recombinant hepatitis B BCG vaccine combined vaccine for intradermal injection and its preparation method
09/14/2005CN1218749C Recombination protein vaccine for preventing animal aphtha virus infection and uses thereof
09/14/2005CN1218748C Foreign duck liver ichthyophthirius active vaccine and preparation method thereof
09/14/2005CN1218742C Medicine for treating acute bacillary dysentery and acute enteritis
09/14/2005CN1218733C Medicine for treating common cold and preparation method
09/14/2005CN1218725C Medicament compsn. for curing acute pharyngitis and its preparation method
09/14/2005CN1218713C Oral liquid 'Mieailing' and its preparing process
09/14/2005CN1218705C Anti SARS virus medicine and synthesizing method thereof
09/14/2005CN1218703C Chitose antibacterial film of uterine neck
09/14/2005CN1218689C Pharmaceutical compositions containing tobramycin and xanthan gum
09/13/2005US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof
09/13/2005US6943243 Control of gene expression in eukaryotic cells
09/13/2005US6943197 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943186 Administering benzopyrazolyl compound for therapy of sepsis
09/13/2005US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005US6943181 Use of substituted gamma-lactone compounds as pharmaceutical preparations
09/13/2005US6943176 Heterocyclic derivatives
09/13/2005US6943175 Nitrogen compounds such as N-(3,5-dibromobenzyl)-N'-(1H-imidazo[4,5-b]pyridin-2-yl)-propane-1,3-diamine, used as inhibitors of methionyl transfer RNA synthetases in bacteria; antibiotics; bactericides
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/13/2005US6943152 DNA vaccine-PCV
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/13/2005US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof
09/13/2005US6942877 Method for producing antibiotic composites
09/13/2005US6942863 Polypeptide for use the prevention of infections associated with tissue grafting
09/13/2005US6942858 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
09/13/2005US6942852 N-terminal modifications of RANTES and methods of use
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2368650C Viral treatment
09/13/2005CA2335394C Aerothricin analogs, their preparation and use
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/12/2005CA2460873A1 Inhibitors of siderophore biosynthesis in fungi
09/09/2005WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha
09/09/2005WO2005083072A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
09/09/2005WO2005083062A1 Cell vaccine
09/09/2005WO2005082919A1 Process for isolation and seperation of 3 biological active compounds from aloe vera leaf gel filet and the 3 compounds
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082899A1 Oxazolidinone derivatives as antimicrobials
09/09/2005WO2005082870A1 Abc transporter inhibitor
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082388A1 Extracts of scutellaria for the treatment of sars
09/09/2005WO2005082373A1 Medicinal eudistomin derivative composition
09/09/2005WO2005082334A1 Sustained-release cream preparation
09/09/2005WO2005051286A3 Stable ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-yloxy) methyl)-2-amine-1h-purin-6(9h)-one.
09/09/2005WO2005028442A3 2-pyridinone derivatives, having hiv inhibiting properties
09/09/2005WO2005027979A3 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
09/09/2005WO2005012358A3 Use of adcc-optimized antibodies for treating weak patients
09/09/2005CA2558155A1 Casein derived peptides and therapeutic uses thereof
09/09/2005CA2557500A1 Methods and compositions for the treatment and prevention of hiv infection using trim5.alpha.
09/09/2005CA2557136A1 Flavivirus vaccines
09/09/2005CA2556437A1 Use of targeted oxidative therapeutic formulation in treatment of viral diseases
09/09/2005CA2555720A1 Isoquinoline derivatives
09/09/2005CA2555173A1 Compositions comprising hiv protease inhibitor and cytochrome p450 enzyme activity inhibitor
09/09/2005CA2555171A1 Therapeutic combinations
09/09/2005CA2548220A1 Use of mda-7 to inhibit infection by pathogenic organisms
09/09/2005CA2546853A1 Use of interfering rna in the production of transgenic animals
09/09/2005CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197334 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory)
09/08/2005US20050197333 Rifamycin analogs and uses thereof
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/08/2005US20050197299 Peptidomimetic protease inhibitors
09/08/2005US20050197284 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease
09/08/2005US20050196456 Controlled release particles
09/08/2005US20050196413 for inducing a mucosal Immunoglobin A immune response and a systemic Immunoglobin G immune response; storage stability
09/08/2005US20050196408 Stimulating an immune response in a primate utilizing bacterial adhesin proteins and/or imunogenic fragments
09/08/2005US20050196385 Lymphocytic cells; industrial production of functional cells, pharmaceutical quality, large amounts; blood, plasma, serum from cytapheresis, frozen stock; cultured with synthetic activators phosphohalohydrin, phosphoepoxide, bisphosphonate,cytokine, interlukin; treat infection, parasites, cancer
1 ... 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 ... 1798